BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22641667)

  • 1. Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer.
    Kinugasa T; Akagi Y; Ochi T; Tanaka N; Kawahara A; Ishibashi Y; Gotanda Y; Yamaguchi K; Shiratuchi I; Oka Y; Kage M; Shirouzu K
    Anticancer Res; 2012 Jun; 32(6):2309-14. PubMed ID: 22641667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased claudin-1 protein expression contributes to tumorigenesis in ulcerative colitis-associated colorectal cancer.
    Kinugasa T; Akagi Y; Yoshida T; Ryu Y; Shiratuchi I; Ishibashi N; Shirouzu K
    Anticancer Res; 2010 Aug; 30(8):3181-6. PubMed ID: 20871038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer.
    Huo Q; Kinugasa T; Wang L; Huang J; Zhao J; Shibaguchi H; Kuroki M; Tanaka T; Yamashita Y; Nabeshima K; Iwasaki H; Kuroki M
    Anticancer Res; 2009 Mar; 29(3):851-7. PubMed ID: 19414319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of metastatic site on the expression of CEA and cellular localization of β-catenin in colorectal cancer.
    Rao US; Hoerster NS; Thirumala S; Rao PS
    J Gastroenterol Hepatol; 2013 Mar; 28(3):505-12. PubMed ID: 23216017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
    Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma.
    Suzuki H; Masuda N; Shimura T; Araki K; Kobayashi T; Tsutsumi S; Asao T; Kuwano H
    Anticancer Res; 2008; 28(3B):1821-30. PubMed ID: 18630466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma.
    Roca F; Mauro LV; Morandi A; Bonadeo F; Vaccaro C; Quintana GO; Specterman S; de Kier Joffé EB; Pallotta MG; Puricelli LI; Lastiri J
    J Surg Oncol; 2006 Feb; 93(2):151-60. PubMed ID: 16425303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
    Tang JQ; Fan Q; Wu WH; Jia ZC; Li H; Yang YM; Liu YC; Wan YL
    Chin Med J (Engl); 2010 Dec; 123(24):3559-65. PubMed ID: 22166631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous expression of claudin-4 in human colorectal cancer: decreased claudin-4 expression at the invasive front correlates cancer invasion and metastasis.
    Ueda J; Semba S; Chiba H; Sawada N; Seo Y; Kasuga M; Yokozaki H
    Pathobiology; 2007; 74(1):32-41. PubMed ID: 17496431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Smad4, E-cadherin and beta-catenin in advanced colorectal cancer: a retrospective study.
    Diab A; Nikolopoulou-Stamati P; Katostaras T; Safioleas M; Kostakis A; Athanassiadou P; Liossi-Ioakeim A; Marinos G; Konstantopoulos K
    J BUON; 2012; 17(1):92-6. PubMed ID: 22517699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
    J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer.
    Kinugasa T; Huo Q; Higashi D; Shibaguchi H; Kuroki M; Tanaka T; Futami K; Yamashita Y; Hachimine K; Maekawa S; Nabeshima K; Iwasaki H; Kuroki M
    Anticancer Res; 2007; 27(6A):3729-34. PubMed ID: 17970035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of RhoGDI2 correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Li X; Wang J; Zhang X; Zeng Y; Liang L; Ding Y
    Ann Surg Oncol; 2012 Jan; 19(1):145-53. PubMed ID: 21861235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.
    Ochiai H; Nakanishi Y; Fukasawa Y; Sato Y; Yoshimura K; Moriya Y; Kanai Y; Watanabe M; Hasegawa H; Kitagawa Y; Kitajima M; Hirohashi S
    Oncology; 2008; 75(1-2):32-41. PubMed ID: 18728370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors.
    Ohji Y; Yao T; Eguchi T; Yamada T; Hirahashi M; Iida M; Tsuneyoshi M
    Oncol Rep; 2007 Mar; 17(3):525-30. PubMed ID: 17273728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.